Acumen Pharmaceuticals, Inc.
ABOS • NASDAQ • Stock Fundamentals
Acumen Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel J. O'Connell, with a market cap of $174.8M.
Market Cap$174.8M
Employees52.0
CEODaniel J. O'Connell
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Acumen Pharmaceuticals, Inc. FAQ
Common questions about Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. (ABOS) has a market capitalization of $174.8M and trades on NASDAQ.
Acumen Pharmaceuticals, Inc. has approximately 52 employees.